A fast-growing market built on hemp-derived cannabinoid products is about to face a federal reset. Over the past several years, consumer demand for products such as hemp-derived THC gummies, beverages, vapes, and flowers helped create thriving new retail categories across mainstream outlets and e-commerce.

But the Continuing Appropriations and Extensions Act, 2026 (2026 CAEA) fundamentally changes the federal definition of lawful hemp and, when it takes effect in November 2026, will significantly narrow which finished products can still be sold as “hemp” under federal law.

For businesses operating in this space, 2026 is less a waiting period than a strategic runway–requiring early decisions about product portfolios, testing and labeling readiness, inventory and contracting, and the likelihood that state responses may accelerate compliance timelines in key markets.

The New Law: A Strict Reinterpretation of Hemp

The Continuing Appropriations and Extensions Act of 2026 (P.L. 119-37), signed by President Trump on November 12, 2025, significantly narrows the federal definition of “hemp.” The new definition will effectively ban most psychoactive hemp-derived cannabinoids when the law takes effect on November 12, 2026. This substantial change in federal policy will have major implications across the hemp and cannabis sector.

Read more at National Law Review